Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT02941783
Drug Use Investigation of Kovaltry in Hemophilia A Patients
Sponsor: Bayer
View on ClinicalTrials.gov
Summary
The objective in this study is collecting post-marketing information on the safety and efficacy of Kovaltry under the routine clinical practice.
Official title: Special Drug Investigation of Kovaltry in Hemophilia A Patients
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
230
Start Date
2016-11-30
Completion Date
2025-09-09
Last Updated
2026-09-09
Healthy Volunteers
No
Conditions
Interventions
DRUG
Kovaltry (Antihemophilic Factor [Recombinant], BAY81-8973)
Treatment parameters following the physician's decision based on the summary of product characteristics.